Just look at his record:
Professor Mark Ferguson’s biotech firm Renovo Limited never made a marketable product, even though more than €170m was invested in it — including a large chunk from the British taxpayer. Prof Ferguson and his wife received more than €18m from their time with the company, which ended last year.
…Despite Renovo never producing a drug that could be marketed, Prof Ferguson received €4.5m in salary, including a payment of over €800,000 when he stepped down. His researcher wife Sharon O’Kane received more than €2m and the pair also netted €12.7m by exercising a director’s option when the shares were at their peak in 2007.
I Can Do Job, Insists Science Chief Whose Own Firm Failed (Edel O’Connell, Irish Independent)
Previously: Understanding The Science Foundation Of Ireland Leak Crisis
The Business of Science In Ireland
